<DOC>
	<DOCNO>NCT01066650</DOCNO>
	<brief_summary>The TWENTE Study single center prospective single-blinded randomize study . Randomization involve type Drug-Eluting Stent ( DES ) use study population . Patients blind type DES receive . The general practitioner patient request disclose information patient . Analysts perform data analysis blind type DES use well .</brief_summary>
	<brief_title>The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study Twente</brief_title>
	<detailed_description>Primary research question To investigate whether clinical outcome follow randomize implantation Endeavor Resolute® versus XIENCE V® drug-eluting stent similar , assess non-inferiority set compare target-vessel failure ( TVF ) stent . We want compare drug-eluting stent combine endpoint death , myocardial infarction revascularization relate target-vessel , well death myocardial infarction relate significant flow obstruction another vessel another cause . According current literature , non-inferiority Endeavor resolute ® XIENCE V® expect . But non-inferiority Endeavor resolute XIENCE V® test control randomize trial yet .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Indication PCI DES implantation base VVC/ESC guideline and/or clinical decision interventional cardiologist Age ≥ 18 year mentally capable give inform consent Signed informed consent Patients STelevation myocardial infarction ( STEMI ) ST elevation myocardial infarction equivalent require primary PCI rescue PCI Patients revascularization procedure plan perform staged approach Renal failure require haemodialysis Patient currently participate investigational drug device study complete In investigator opinion patient comorbid condition ( ) could limit patient 's ability participate study , compliance followup requirement impact scientific integrity study Life expectancy less 1 year Patients PCI indication DES use and/or operator choose use DES base clinical situation , patient exclude . If choice DES dictate logistic reason e.g . require DES dimension provide one manufacturer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>TWENTE</keyword>
	<keyword>randomize study</keyword>
	<keyword>stent</keyword>
	<keyword>coronary stent</keyword>
	<keyword>drug-eluting stent</keyword>
	<keyword>Zotarolimus</keyword>
	<keyword>Everolimus</keyword>
	<keyword>Xience V</keyword>
	<keyword>Endeavor Resolute</keyword>
	<keyword>head head comparison</keyword>
	<keyword>real world patient</keyword>
	<keyword>target vessel failure</keyword>
	<keyword>investigator initiate study</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>coronary artery</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>non inferiority</keyword>
</DOC>